|
GALNT3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.99279983812562E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.72454999999294E-05 |
| Normal-vs-Stage2 |
2.232800E-04 |
| Normal-vs-Stage3 |
1.11810000147372E-08 |
| Normal-vs-Stage4 |
2.36910002726631E-09 |
| Stage1-vs-Stage2 |
6.142800E-01 |
| Stage1-vs-Stage3 |
1.622030E-04 |
| Stage1-vs-Stage4 |
1.49890000000763E-06 |
| Stage2-vs-Stage3 |
1.234020E-01 |
| Stage2-vs-Stage4 |
4.103500E-02 |
| Stage3-vs-Stage4 |
2.319200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.00780000029155E-07 |
| Normal-vs-AfricanAmerican |
1.102360E-03 |
| Normal-vs-Asian |
1.84276999999344E-05 |
| Caucasian-vs-AfricanAmerican |
2.262600E-01 |
| Caucasian-vs-Asian |
4.776800E-01 |
| AfricanAmerican-vs-Asian |
7.001900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.81209999958487E-07 |
| Normal-vs-Female |
1.704120E-03 |
| Male-vs-Female |
6.922000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.75340000000612E-05 |
| Normal-vs-Extreme_Weight |
1.3108999996625E-07 |
| Normal-vs-Obese |
9.20049999963979E-07 |
| Normal-vs-Extreme_Obese |
3.857800E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.215800E-01 |
| Normal_Weight-vs-Obese |
8.087200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.204600E-01 |
| Extreme_Weight-vs-Obese |
2.015000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.972600E-01 |
| Obese-vs-Extreme_Obese |
9.081200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.761930E-03 |
| Normal-vs-Age(41-60Yrs) |
3.39620000011642E-07 |
| Normal-vs-Age(61-80Yrs) |
1.50076999999582E-05 |
| Normal-vs-Age(81-100Yrs) |
1.0732999999874E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.271400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.117600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.324100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.134760E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.109200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.426200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.48400000025084E-07 |
| Normal-VS-Type2 PRCC |
1.83689999988523E-07 |
| Normal-VS-KIRP CIMP |
1.820380E-02 |
| Normal-VS-Unclassified PRCC |
4.37829999999639E-06 |
| Type1 PRCC-VS-Type2 PRCC |
5.443400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.506600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.901800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.733000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.801600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.394600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.26079999960427E-08 |
| Normal-vs-N1 |
6.88029999640349E-08 |
| Normal-vs-N2 |
2.55089949163789E-10 |
| N0-vs-N1 |
6.734400E-01 |
| N0-vs-N2 |
1.96845999999029E-05 |
| N1-vs-N2 |
4.618900E-03 |
|
|
